DiscoverQ&A with FDASwitching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim
Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim

Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim

Update: 2024-05-03
Share

Description

Listen to our latest podcast series, Q&A with FDA, on Switching Between Biosimilars and Their Reference Counterparts, featuring Dr. Sarah Yim.
Comments 
In Channel
Clinical Trial Basics

Clinical Trial Basics

2022-09-2912:28

00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim

Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim

U.S. Food and Drug Administration, Center for Drug Evaluation and Research